Neurovascular and neurometabolic derailment in aging and alzheimer's disease

Frontiers in Aging Neuroscience

Volumn 7, Issue MAY, 2015, Pages

  Lourenço, Cátia F ^a   Ledo, Ana ^a   Dias, Cândida ^a   Barbosa, Rui M ^a,b   Laranjinha, João ^a,b  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Aging; Alzheimer's disease; Neurometabolism; Neurovascular coupling; Nitric oxide

Indexed keywords

NITRIC OXIDE;

AGING; ALZHEIMER DISEASE; BRAIN CIRCULATION; BRAIN DYSFUNCTION; BRAIN METABOLISM; BRAIN PERFUSION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENERGY METABOLISM; HIPPOCAMPUS; HUMAN; HYPERCHOLESTEROLEMIA; INSULIN RESISTANCE; METABOLIC SYNDROME X; NERVE DEGENERATION; NEUROMETABOLIC COUPLING; NEUROTRANSMISSION; NEUROVASCULAR COUPLING; NONHUMAN; PATHOGENESIS; SHORT SURVEY; SIGNAL TRANSDUCTION;

EID: 84931266835     PISSN: None     EISSN: 16634365     Source Type: Journal    
DOI: 10.3389/fnagi.2015.00103     Document Type: Short Survey

References (85)

1. Almeida, A., Cidad, P., Delgado-Esteban, M., Fernandez, E., Garcia-Nogales, P., and Bolanos, J. P. (2005). Inhibition of mitochondrial respiration by nitric oxide: its role in glucose metabolism and neuroprotection. J. Neurosci. Res. 79, 166-171. doi: 10.1002/jnr.20281
2. Alsop, D. C., Detre, J. A., and Grossman, M. (2000). Assessment of cerebral blood flow in Alzheimer's disease by spin-labeled magnetic resonance imaging. Ann. Neurol. 47, 93-100. doi: 10.1002/1531-8249(200001)47:1<93::AID-ANA15>3.0.CO;2-8
3. Antunes, F., and Cadenas, E. (2007). The mechanism of cytochrome C oxidase inhibition by nitric oxide. Front. Biosci. 12:2118. doi: 10.2741/2118
4. Attwell, D., Buchan, A. M., Charpak, S., Lauritzen, M., Macvicar, B. A., and Newman, E. A. (2010). Glial and neuronal control of brain blood flow. Nature 468, 232-43. doi: 10.1038/nature09613
5. Bader Lange, M. L., Cenini, G., Piroddi, M., Abdul, H. M., Sultana, R., Galli, F., et al. (2008). Loss of phospholipid asymmetry and elevated brain apoptotic protein levels in subjects with amnestic mild cognitive impairment and Alzheimer disease. Neurobiol. Dis. 29, 456-464. doi: 10.1016/j.nbd.2007.11.004
6. Barzilai, N., Huffman, D. M., Muzumdar, R. H., and Bartke, A. (2012). The critical role of metabolic pathways in aging. Diabetes 61, 1315-1322. doi: 10.2337/db11-1300
7. Bell, R. D., and Zlokovic, B. V. (2009). Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease. Acta Neuropathol. 118, 103-113. doi: 10.1007/s00401-009-0522-3
8. Bolanos, J. P., Delgado-Esteban, M., Herrero-Mendez, A., Fernandez-Fernandez, S., and Almeida, A. (2008). Regulation of glycolysis and pentose-phosphate pathway by nitric oxide: impact on neuronal survival. Biochim. Biophys. Acta 1777, 789-793. doi: 10.1016/j.bbabio.2008.05.179
9. Brown, G. C. (2007). Nitric oxide and mitochondria. Front. Biosci. 12:2122. doi: 10.2741/2122
10. Cadenas, E. (2004). Mitochondrial free radical production and cell signaling. Mol. Aspects Med. 25, 17-26. doi: 10.1016/j.mam.2004.02.005
11. Casley, C. S., Land, J. M., Sharpe, M. A., Clark, J. B., Duchen, M. R., and Canevari, L. (2002). Beta-amyloid fragment 25-35 causes mitochondrial dysfunction in primary cortical neurons. Neurobiol. Dis. 10, 258-267. doi: 10.1006/nbdi.2002.0516
12. Castegna, A., Lauderback, C. M., Mohmmad-Abdul, H., and Butterfield, D. A. (2004). Modulation of phospholipid asymmetry in synaptosomal membranes by the lipid peroxidation products, 4-hydroxynonenal and acrolein: implications for Alzheimer's disease. Brain Res. 1004, 193-197. doi: 10.1016/j.brainres.2004.01.036
13. Chaturvedi, R. K., and Flint Beal, M. (2013). Mitochondrial diseases of the brain. Free Radic. Biol. Med. 63, 1-29. doi: 10.1016/j.freeradbiomed.2013.03.018
14. Christopherson, K. S., Hillier, B. J., Lim, W. A., and Bredt, D. S. (1999). PSD-95 assembles a ternary complex with the N-methyl-D-aspartic acid receptor and a bivalent neuronal NO synthase PDZ domain. J. Biol. Chem. 274, 27467-27473. doi: 10.1074/jbc.274.39.27467
15. Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., et al. (1993). Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261, 921-923. doi: 10.1126/science.8346443
16. de la Torre, J. C. (2012). Cerebral hemodynamics and vascular risk factors: setting the stage for Alzheimer's disease. J. Alzheimers Dis. 32, 553-567. doi: 10.3233/JAD-2012-120793
17. de Leon, M. J., Ferris, S. H., George, A. E., Christman, D. R., Fowler, J. S., Gentes, C., et al. (1983). Positron emission tomographic studies of aging and Alzheimer disease. AJNR Am. J. Neuroradiol. 4, 568-571.
18. Duarte, J. M., Schuck, P. F., Wenk, G. L., and Ferreira, G. C. (2014). Metabolic disturbances in diseases with neurological involvement. Aging Dis. 5, 238-255. doi: 10.14336/AD.2014.0500238
19. Fabiani, M., Gordon, B. A., Maclin, E. L., Pearson, M. A., Brumback-Peltz, C. R., Low, K. A., et al. (2014). Neurovascular coupling in normal aging: a combined optical, ERP and fMRI study. Neuroimage 85(Pt 1), 592-607. doi: 10.1016/j.neuroimage.2013.04.113
20. Fernandez-Vizarra, P., Fernandez, A. P., Castro-Blanco, S., Encinas, J. M., Serrano, J., Bentura, M. L., et al. (2004). Expression of nitric oxide system in clinically evaluated cases of Alzheimer's disease. Neurobiol. Dis. 15, 287-305. doi: 10.1016/j.nbd.2003.10.010
21. Fisher, J. P., Hartwich, D., Seifert, T., Olesen, N. D., McNulty, C. L., Nielsen, H. B., et al. (2013). Cerebral perfusion, oxygenation and metabolism during exercise in young and elderly individuals. J. Physiol. 591(Pt 7), 1859-1870. doi: 10.1113/jphysiol.2012.244905
22. Fleisher, A. S., Podraza, K. M., Bangen, K. J., Taylor, C., Sherzai, A., Sidhar, K., et al. (2009). Cerebral perfusion and oxygenation differences in Alzheimer's disease risk. Neurobiol. Aging 30, 1737-1748. doi: 10.1016/j.neurobiolaging.2008.01.012
23. Gearing, M., Mirra, S. S., Hedreen, J. C., Sumi, S. M., Hansen, L. A., and Heyman, A. (1995). The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part X. Neuropathology confirmation of the clinical diagnosis of Alzheimer's disease. Neurology 45(3 Pt 1), 461-466. doi: 10.1212/WNL.45.3.461
24. Girouard, H., and Iadecola, C. (2006). Neurovascular coupling in the normal brain and in hypertension, stroke, and Alzheimer disease. J. Appl. Physiol. 100, 328-335. doi: 10.1152/japplphysiol.00966.2005
25. Giulivi, C. (2003). Characterization and function of mitochondrial nitric-oxide synthase. Free Radic. Biol. Med. 34, 397-408. doi: 10.1016/S0891-5849(02)01298-4
26. Gordon, G. R., Choi, H. B., Rungta, R. L., Ellis-Davies, G. C., and MacVicar, B. A. (2008). Brain metabolism dictates the polarity of astrocyte control over arterioles. Nature 456, 745-79. doi: 10.1038/nature07525
27. Guix, F. X., Uribesalgo, I., Coma, M., and Munoz, F. J. (2005). The physiology and pathophysiology of nitric oxide in the brain. Prog. Neurobiol. 76, 126-152. doi: 10.1016/j.pneurobio.2005.06.001
28. Hamel, E., Nicolakakis, N., Aboulkassim, T., Ongali, B., and Tong, X. K. (2008). Oxidative stress and cerebrovascular dysfunction in mouse models of Alzheimer's disease. Exp. Physiol. 93, 116-120. doi: 10.1113/expphysiol.2007.038729
29. Haralampos, J. M., Matilda, F., and Sotirios, G. (2008). Metabolic syndrome and Alzheimer's disease: a link to a vascular hypothesis? CNS Spectr. 13, 606-613. doi: 10.1017/S1092852900016886
30. Harris, J. J., Jolivet, R., and Attwell, D. (2012). Synaptic energy use and supply. Neuron 75, 762-777. doi: 10.1016/j.neuron.2012.08.019
31. Heinrich, T. A., da Silva, R. S., Miranda, K. M., Switzer, C. H., Wink, D. A., and Fukuto, J. M. (2013). Biological nitric oxide signaling: chemistry and terminology (NO chemical biology and terminology). Br. J. Pharmacol. 169, 1417-1429. doi: 10.1111/bph.12217
32. Hsia, A. Y., Masliah, E., McConlogue, L., Yu, G. Q., Tatsuno, G., Hu, K., et al. (1999). Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. Proc. Natl. Acad. Sci. U.S.A. 96, 3228-3233. doi: 10.1073/pnas.96.6.3228
33. Iadecola, C. (1993). Regulation of the cerebral microcirculation during neural activity: is nitric oxide the missing link? Trends Neurosci. 16, 206-214. doi: 10.1016/0166-2236(93)90156-G
34. Iadecola, C. (2004). Neurovascular regulation in the normal brain and in Alzheimer's disease. Nat. Rev. Neurosci. 5, 347-360. doi: 10.1038/nrn1387
35. Iadecola, C., Zhang, F., Niwa, K., Eckman, C., Turner, S. K., Fischer, E., et al. (1999). SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein. Nat. Neurosci. 2, 157-161. doi: 10.1038/5715
36. Jellinger, K. A., and Mitter-Ferstl, E. (2003). The impact of cerebrovascular lesions in Alzheimer disease-a comparative autopsy study. J. Neurol. 250, 1050-1055. doi: 10.1007/s00415-003-0142-0
37. Kalaria, R. N. (2012). Cerebrovascular disease and mechanisms of cognitive impairment: evidence from clinicopathological studies in humans. Stroke 43, 2526-2534. doi: 10.1161/strokeaha.112.655803
38. Kealy, J., Bennett, R., and Lowry, J. P. (2013). Simultaneous recording of hippocampal oxygen and glucose in real time using constant potential amperometry in the freely-moving rat. J. Neurosci. Methods 215, 110-120. doi: 10.1016/j.jneumeth.2013.02.016
39. Kish, S. J., Bergeron, C., Rajput, A., Dozic, S., Mastrogiacomo, F., Chang, L. J., et al. (1992). Brain cytochrome oxidase in Alzheimer's disease. J. Neurochem. 59, 776-779. doi: 10.1111/j.1471-4159.1992.tb09439.x
40. Koike, M. A., Green, K. N., Blurton-Jones, M., and Laferla, F. M. (2010). Oligemic hypoperfusion differentially affects tau and amyloid-{beta}. Am. J. Pathol. 177, 300-310. doi: 10.2353/ajpath.2010.090750
41. Krejza, J., Mariak, Z., Walecki, J., Szydlik, P., Lewko, J., and Ustymowicz, A. (1999). Transcranial color Doppler sonography of basal cerebral arteries in 182 healthy subjects: age and sex variability and normal reference values for blood flow parameters. AJR Am. J. Roentgenol. 172, 213-218. doi: 10.2214/ajr.172.1.9888770
42. Ledo, A., Barbosa, R., Cadenas, E., and Laranjinha, J. (2010). Dynamic and interacting profiles of *NO and O2 in rat hippocampal slices. Free Radic. Biol. Med. 48, 1044-1050. doi: 10.1016/j.freeradbiomed.2010.01.024
43. Ledo, A., Barbosa, R., Gerhardtt, G., Cadenas, E., and Laranjinha, J. (2005). Concentration dynamics of nitric oxide in rat hippocampal subregions evoked by stimulation of the NMDA glutamate receptor. Proc. Natl. Acad. Sci. U.S.A. 102, 17483-17488. doi: 10.1073/pnas.0503624102
44. Ledo, A., Lourenço, C. F., Caetano, M., Barbosa, R. M., and Laranjinha, J. (2015). Age-associated changes of nitric oxide concentration dynamics in the central nervous system of fisher 344 rats. Cell. Mol. Neurobiol. 35, 33-44. doi: 10.1007/s10571-014-0115-0
45. Lesne, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., et al. (2006). A specific amyloid-beta protein assembly in the brain impairs memory. Nature 440, 352-357. doi: 10.1038/nature04533
46. Lesne, S., and Kotilinek, L. (2005). Amyloid plaques and amyloid-beta oligomers: an ongoing debate. J. Neurosci. 25, 9319-9320. doi: 10.1523/JNEUROSCI.3246-05.2005
47. Lin, M. T., Simon, D. K., Ahn, C. H., Kim, L. M., and Beal, M. F. (2002). High aggregate burden of somatic mtDNA point mutations in aging and Alzheimer's disease brain. Hum. Mol. Genet. 11, 133-145. doi: 10.1093/hmg/11.2.133
48. Lourenço, C. F., Ferreira, N. R., Santos, R. M., Lukacova, N., Barbosa, R. M., and Laranjinha, J. (2014b). The pattern of glutamate-induced nitric oxide dynamics in vivo and its correlation with nNOS expression in rat hippocampus, cerebral cortex and striatum. Brain Res. 1554, 1-11. doi: 10.1016/j.brainres.2014.01.030
49. Lourenço, C. F., Santos, R., Barbosa, R. M., Gerhardt, G., Cadenas, E., and Laranjinha, J. (2011). In vivo modulation of nitric oxide concentration dynamics upon glutamatergic neuronal activation in the hippocampus. Hippocampus 21, 622-630. doi: 10.1002/hipo.20774
50. Lourenço, C. F., Santos, R. M., Barbosa, R. M., Cadenas, E., Radi, R., and Laranjinha, J. (2014a). Neurovascular coupling in hippocampus is mediated via diffusion by neuronal-derived nitric oxide. Free Radic. Biol. Med. 73, 421-49. doi: 10.1016/j.freeradbiomed.2014.05.021
51. Manczak, M., Anekonda, T. S., Henson, E., Park, B. S., Quinn, J., and Reddy, P. H. (2006). Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression. Hum. Mol. Genet. 15, 1437-1449. doi: 10.1093/hmg/ddl066
52. Maurer, I., Zierz, S., and Möller, H. J. (2000). A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients. Neurobiol. Aging 21, 455-462. doi: 10.1016/S0197-4580(00)00112-3
53. Melov, S., Adlard, P. A., Morten, K., Johnson, F., Golden, T. R., Hinerfeld, D., et al. (2007). Mitochondrial oxidative stress causes hyperphosphorylation of tau. PLoS ONE 2:e536 doi: 10.1371/journal.pone.0000536
54. Mohmmad Abdul, H., and Butterfield, D. A. (2005). Protection against amyloid beta-peptide (1-42)-induced loss of phospholipid asymmetry in synaptosomal membranes by tricyclodecan-9-xanthogenate (D609) and ferulic acid ethyl ester: implications for Alzheimer's disease. Biochim. Biophys. Acta 1741, 140-148. doi: 10.1016/j.bbadis.2004.12.002
55. Moncada, S., and Bolaños, J. P. (2006). Nitric oxide, cell bioenergetics and neurodegeneration. J. Neurochem. 97, 1676-189. doi: 10.1111/j.1471-4159.2006.03988.x
56. Mosconi, L., Tsui, W. H., De Santi, S., Li, J., Rusinek, H., Convit, A., et al. (2005). Reduced hippocampal metabolism in MCI and AD: automated FDG-PET image analysis. Neurology 64, 1860-1867. doi: 10.1212/01.WNL.0000163856.13524.08
57. Mucke, L., Yu, G. Q., McConlogue, L., Rockenstein, E. M., Abraham, C. R., and Masliah, E. (2000). Astroglial expression of human alpha(1)-antichymotrypsin enhances alzheimer-like pathology in amyloid protein precursor transgenic mice. Am. J. Pathol. 157, 2003-2010. doi: 10.1016/S0002-9440(10)64839-0
58. Mutisya, E. M., Bowling, A. C., and Beal, M. F. (1994). Cortical cytochrome oxidase activity is reduced in Alzheimer's disease. J. Neurochem. 63, 2179-2184. doi: 10.1046/j.1471-4159.1994.63062179.x
59. Niwa, K., Carlson, G. A., and Iadecola, C. (2000b). Exogenous A beta1-40 reproduces cerebrovascular alterations resulting from amyloid precursor protein overexpression in mice. J. Cereb. Blood Flow Metab. 20, 1659-1668. doi: 10.1097/00004647-200012000-00005
60. Niwa, K., Kazama, K., Younkin, S. G., Carlson, G. A., and Iadecola, C. (2002). Alterations in cerebral blood flow and glucose utilization in mice overexpressing the amyloid precursor protein. Neurobiol. Dis. 9, 61-68. doi: 10.1006/nbdi.2001.0460
61. Niwa, K., Porter, V. A., Kazama, K., Cornfield, D., Carlson, G. A., and Iadecola, C. (2001). A beta-peptides enhance vasoconstriction in cerebral circulation. Am. J. Physiol. Heart Circ. Physiol. 281, H2417-H2424.
62. Niwa, K., Younkin, L., Ebeling, C., Turner, S. K., Westaway, D., Younkin, S., et al. (2000a). Abeta 1-40-related reduction in functional hyperemia in mouse neocortex during somatosensory activation. Proc. Natl. Acad. Sci. U.S.A. 97, 9735-9740. doi: 10.1073/pnas.97.17.9735
63. Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., et al. (2003). Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 39, 409-421. doi: 10.1016/S0896-6273(03)00434-3
64. Palamalai, V., and Miyagi, M. (2010). Mechanism of glyceraldehyde-3-phosphate dehydrogenase inactivation by tyrosine nitration. Protein Sci. 19, 255-62. doi: 10.1002/pro.311
65. Petrella, J. R., Coleman, R. E., and Doraiswamy, P. M. (2003). Neuroimaging and early diagnosis of Alzheimer disease: a look to the future. Radiology 226, 315-336. doi: 10.1148/radiol.2262011600
66. Prast, H., and Philippu, A. (2001). Nitric oxide as modulator of neuronal function. Prog. Neurobiol. 64, 51-68. doi: 10.1016/S0301-0082(00)00044-7
67. Rancillac, A., Rossier, J., Guille, M., Tong, X. K., Geoffroy, H., Amatore, C., et al. (2006). Glutamatergic control of microvascular tone by distinct GABA neurons in the cerebellum. J. Neurosci. 26, 6997-7006. doi: 10.1523/jneurosci.5515-05.2006
68. Reiman, E. M., Chen, K., Alexander, G. E., Caselli, R. J., Bandy, D., Osborne, D., et al. (2005). Correlations between apolipoprotein E epsilon4 gene dose and brain-imaging measurements of regional hypometabolism. Proc. Natl. Acad. Sci. U.S.A. 102, 8299-8302. doi: 10.1073/pnas.0500579102
69. Rossignol, R., Faustin, B., Rocher, C., Malgat, M., Mazat, J. P., and Letellier, T. (2003). Mitochondrial threshold effects. Biochem. J. 370(Pt 3), 751-62. doi: 10.1042/bj20021594
70. Ruitenberg, A., den Heijer, T., Bakker, S. L., van Swieten, J. C., Koudstaal, P. J., Hofman, A., et al. (2005). Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam Study. Ann. Neurol. 57, 789-794. doi: 10.1002/ana.20493
71. Scholl, M., Almkvist, O., Axelman, K., Stefanova, E., Wall, A., Westman, E., et al. (2011). Glucose metabolism and PIB binding in carriers of a His163Tyr presenilin 1 mutation. Neurobiol. Aging 32, 1388-1399. doi: 10.1016/j.neurobiolaging.2009.08.016
72. Schultz, S. K., O'Leary, D. S., Boles Ponto, L. L., Watkins, G. L., Hichwa, R. D., and Andreasen, N. C. (1999). Age-related changes in regional cerebral blood flow among young to mid-life adults. Neuroreport 10, 2493-2496. doi: 10.1097/00001756-199908200-00011
73. Shulman, R. G., and Rothman, D. L. (1998). Interpreting functional imaging studies in terms of neurotransmitter cycling. Proc. Natl. Acad. Sci. U.S.A. 95, 11993-11998. doi: 10.1073/pnas.95.20.11993
74. Swerdlow, R. H. (2007). Is aging part of Alzheimer's disease, or is Alzheimer's disease part of aging? Neurobiol. Aging 28, 1465-1480. doi: 10.1016/j.neurobiolaging.2006.06.021
75. Swerdlow, R. H., Burns, J. M., and Khan, S. M. (2014). The Alzheimer's disease mitochondrial cascade hypothesis: progress and perspectives. Biochim. Biophys. Acta 1842, 1219-1231. doi: 10.1016/j.bbadis.2013.09.010
76. Thomas, T., Thomas, G., McLendon, C., Sutton, T., and Mullan, M. (1996). beta-Amyloid-mediated vasoactivity and vascular endothelial damage. Nature 380, 168-171. doi: 10.1038/380168a0
77. Velliquette, R. A., O'Connor, T., and Vassar, R. (2005). Energy inhibition elevates beta-secretase levels and activity and is potentially amyloidogenic in APP transgenic mice: possible early events in Alzheimer's disease pathogenesis. J. Neurosci. 25, 10874-10883. doi: 10.1523/JNEUROSCI.2350-05.2005
78. Venturini, G., Colasanti, M., Persichini, T., Fioravanti, E., Ascenzi, P., Palomba, L., et al. (2002). Beta-amyloid inhibits NOS activity by subtracting NADPH availability. FASEB J. 16, 1970-1972. doi: 10.1096/fj.02-0186fje
79. Victor, V. M., Nunez, C., D'Ocon, P., Taylor, C. T., Esplugues, J. V., and Moncada, S. (2009). Regulation of oxygen distribution in tissues by endothelial nitric oxide. Circ. Res. 104, 1178-1183. doi: 10.1161/circresaha.109.197228
80. Wallace, D. C. (1992). Mitochondrial genetics: a paradigm for aging and degenerative diseases? Science 256, 628-632. doi: 10.1126/science.1533953
81. Walsh, D. M., Klyubin, I., Shankar, G. M., Townsend, M., Fadeeva, J. V., Betts, V., et al. (2005). The role of cell-derived oligomers of Abeta in Alzheimer's disease and avenues for therapeutic intervention. Biochem. Soc. Trans. 33(Pt 5), 1087-1090. doi: 10.1042/BST20051087
82. Winkler, S. R., and Luer, M. S. (1998). Antiepileptic drug review: part 1. Surg. Neurol. 49, 449-452. doi: 10.1016/S0090-3019(97)00223-1
83. Xu, G., Antuono, P. G., Jones, J., Xu, Y., Wu, G., Ward, D., et al. (2007). Perfusion fMRI detects deficits in regional CBF during memory-encoding tasks in MCI subjects. Neurology 69, 1650-1656. doi: 10.1212/01.wnl.0000296941.06685.22
84. Yin, F., Boveris, A., and Cadenas, E. (2014). Mitochondrial energy metabolism and redox signaling in brain aging and neurodegeneration. Antioxid. Redox Signal. 20, 353-371. doi: 10.1089/ars.2012.4774
85. Zlokovic, B. V. (2011). Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nat. Rev. Neurosci. 12, 723-738. doi: 10.1038/nrn3114